UNLOCKING THE WAY FORWARD FOR CDMO BIOTECH: HOW ASYMCHEM BOSTON CORPORATION IS LEADING THE WAY IN R&D INNOVATION

During the quick-paced earth of biotechnology, corporations that specialize in Agreement Enhancement and Manufacturing Companies (CDMO) are driving critical improvements. One of several market’s frontrunners, Asymchem, has set up by itself as a world leader, combining skills in chiral pool synthesis, Highly developed CDMO biotech, and groundbreak